EUVIMEDEUVIMED entdecken
Crossref

Development and Verification of a Japanese Pediatric Physiologically Based Pharmacokinetic Model with Emphasis on Drugs Eliminated by Cytochrome P450 or Renal Excretion

Trevor N Johnson, Khaled Abduljalil iD, Xian Pan, Chie Emoto

The Journal of Clinical Pharmacology · 2023

DOI: 10.1002/jcph.2317 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Pharmacology, 2023. Verfasst von Trevor N Johnson und 3 weiteren Autor:innen. Beteiligte Einrichtung: Simcyp Division, Certara UK Limited, Sheffield, UK. Hauptthemen laut MEDLINE: Cytochrome P-450 CYP3A, Renal Elimination. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 71 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Physiologically based pharmacokinetic (PBPK) models are useful in bridging drug exposure in different ethnic groups, and there is increasing regulatory application of this approach in adults. Reported pediatric PBPK models tend to focus on the North European population, with few examples in other ethnic groups. This study describes the development and verification of a Japanese pediatric PBPK population. The development of the model was based on the existing North European pediatric population. Japanese systems and clinical data were collated from public databases and the literature, and the underlying demographics and equations were optimized so that physiological outputs represented the Japanese pediatric population. The model was tested using 14 different small molecule drugs, eliminated by a variety of pathways, including cytochrome P450 3A4 (CYP3A4) metabolism and renal excretion. Given the limitations of the clinical data, the overall performance of the model was good, with 44/62 predictions for PK parameters (area under the plasma drug concentration–time curve, AUC; maximum serum concentration, C max ; clearance, CL) being within 0.8‐ to 1.25‐fold, 56/62 within 0.67‐ to 1.5‐fold, and 61/62 within 0.5‐ to 2.0‐fold of the observed values. Specific results for the 5 CYP3A4 substrates showed 20/31 cases were predicted within 0.8‐ to 1.25‐fold, 27/31 within 0.67‐ to 1.5‐fold, and all were within 0.5‐ to 2.0‐fold of the observed values. Given the increased regulatory use of pediatric PBPK in drug development, expanding these models to other ethnic groups are important. Considering qualifying these models based on the context of use, there is a need to expand on the current research to include a larger range of drugs with different elimination pathways. Collaboration among academic, industry, model providers, and regulators will facilitate further development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cytochrome P-450 CYP3ARenal EliminationChildHumansComputer SimulationCytochrome P-450 Enzyme SystemDrug InteractionsEast Asian PeopleModels, Biological

Stichwörter der Autor:innen

JapanesePBPK modelingmodel verificationontogenypediatrics

Substanzen

Cytochrome P-450 CYP3ACytochrome P-450 Enzyme System

Autor:innen und Institutionen

  • Simcyp Division, Certara UK Limited, Sheffield, UK.
  • Laboratory of Drug Metabolism and Pharmacokinetics, Showa Pharmaceutical University, Tokyo, Japan.
  • Translational Research Division, Chugai Pharmaceutical Co., Ltd, Tokyo, Japan.

ORCID-Profile: Khaled Abduljalil

Zitieren

APA

Johnson, T. N., Abduljalil, K., Pan, X., & Emoto, C. (2023). Development and Verification of a Japanese Pediatric Physiologically Based Pharmacokinetic Model with Emphasis on Drugs Eliminated by Cytochrome P450 or Renal Excretion. The Journal of Clinical Pharmacology. https://doi.org/10.1002/jcph.2317

Vancouver

Johnson TN, Abduljalil K, Pan X, Emoto C. Development and Verification of a Japanese Pediatric Physiologically Based Pharmacokinetic Model with Emphasis on Drugs Eliminated by Cytochrome P450 or Renal Excretion. The Journal of Clinical Pharmacology. 2023. doi:10.1002/jcph.2317

BibTeX
@article{Johnson2023,
  author = {Johnson, Trevor N and Abduljalil, Khaled and Pan, Xian and Emoto, Chie},
  title = {Development and Verification of a Japanese Pediatric Physiologically Based Pharmacokinetic Model with Emphasis on Drugs Eliminated by Cytochrome P450 or Renal Excretion},
  journal = {The Journal of Clinical Pharmacology},
  year = {2023},
  doi = {10.1002/jcph.2317}
}
Kostenlos starten →